Question 1 · Hard
A 29-year-old woman lives with a relative who was treated for TB in another country; his treatment outcome is unknown. She has had cough and night sweats for 6 weeks. Sputum results: Ziehl-Neelsen smear 2+; Xpert MTB/RIF 'MTB detected medium; RIF resistance not detected'. The MGIT culture flags positive on day 11, the broth shows corded acid-fast bacilli, and the MPT64 antigen test on the broth is positive. Before the isolate is reported as drug-susceptible TB, which further test is most important?
- AA second Xpert MTB/RIF on the cultured isolate
- BIsoniazid susceptibility by line probe assay or DST
- CFluoroquinolone and linezolid susceptibility only
- DNo further test; Xpert has excluded resistance
Show answerHide answer
Answer: B · Isoniazid susceptibility by line probe assay or DST
The corded, MPT64-positive isolate confirms M. tuberculosis complex. Xpert MTB/RIF examines only the rpoB core region, so it predicts rifampicin resistance but gives no information on isoniazid. Isoniazid-resistant, rifampicin-susceptible TB (Hr-TB) is common worldwide and is missed when Xpert is the only test, and a contact of a patient with an unknown outcome is at higher risk of resistance. WHO recommends testing for isoniazid resistance, by a line probe assay that detects katG and inhA mutations, a newer molecular assay or phenotypic DST, so the regimen can be changed if needed. Second-line testing for fluoroquinolones is prioritised when rifampicin resistance is detected.
- A: Repeating Xpert retests the same rpoB region and adds nothing on isoniazid.
- C: Second-line testing is the priority when rifampicin resistance is found.
- D: Xpert MTB/RIF detects rifampicin resistance only, not isoniazid resistance.